<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="99289">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02084758</url>
  </required_header>
  <id_info>
    <org_study_id>ABR-47701</org_study_id>
    <nct_id>NCT02084758</nct_id>
  </id_info>
  <brief_title>Nitrate Supplementation in Chronic Obstructive Pulmonary Disease (COPD)</brief_title>
  <official_title>Nitrate Supplementation to Improve Metabolic Efficiency in Patients With COPD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <authority>Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Each subject will consume (in a randomized fashion) both the intervention beverage (nitrate
      solution) and the placebo, separated by a 1 wk washout period. The investigators will test
      the hypothesis that 7 days of dietary nitrate supplementation will improve metabolic
      efficiency in patients with COPD compared to the placebo.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in metabolic efficiency during exercise</measure>
    <time_frame>Baseline, day 7, day 14 and day 21.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Metabolic efficiency (degree of efficiently used energy during exercise) will be assessed during the test days before and after the two supplementation periods (active and placebo) for a total timespan of 3 weeks.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in blood pressure during exercise</measure>
    <time_frame>Baseline, day 7, day 14 and day 21.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Change in blood pressure will be assessed during the test days before and after the two supplementation periods (active and placebo) for a total timespan of 3 weeks.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in dyspnea during exercise</measure>
    <time_frame>Baseline, day 7, day 14 and day 21.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Change in dyspnea will be assessed during the test days before and after the two supplementation periods (active and placebo) for a total timespan of 3 weeks.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in cycle endurance time during exercise.</measure>
    <time_frame>Baseline, day 7, day 14 and day 21.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Change in cycle endurance time will be assessed during the test days before and after the two supplementation periods (active and placebo) for a total timespan of 3 weeks.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>Nitrate supplementation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sodium nitrate solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo supplementation</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Sodium chloride solution</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Nitrate supplementation</intervention_name>
    <description>7 days of supplementation with sodium nitrate solution</description>
    <arm_group_label>Nitrate supplementation</arm_group_label>
    <arm_group_label>Placebo supplementation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo supplementation</intervention_name>
    <description>7 days of supplementation with sodium chloride solution</description>
    <arm_group_label>Nitrate supplementation</arm_group_label>
    <arm_group_label>Placebo supplementation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  COPD

          -  Indication metabolic inefficiency

        Exclusion Criteria:

          -  Currently supplementing diet with nitrate

          -  Long-term oxygen therapy

          -  Exacerbation of symptoms in the preceding 4 weeks

          -  Pregnancy

          -  Use of medications that may interact with nitrate

          -  Contra-indications for performing (sub)maximal cycle ergometry
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Annemie Schols, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Maastricht University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Coby van de Bool, MSc</last_name>
    <email>coby.vandebool@maastrichtuniversity.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Center of expertise for organ failure (CIRO+)</name>
      <address>
        <city>Horn</city>
        <state>Limburg</state>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Coby van de Bool, MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 10, 2014</lastchanged_date>
  <firstreceived_date>February 17, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>nitrate supplementation</keyword>
  <keyword>metabolic efficiency</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Respiration Disorders</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
